@prefix config: . @prefix meta: . @prefix rdf: . @prefix rdfs: . @prefix xsd: . @prefix owl: . @prefix dc: . @prefix dcmitype: . @prefix dcterms: . @prefix foaf: . @prefix geo: . @prefix om: . @prefix locn: . @prefix schema: . @prefix skos: . @prefix dbpedia: . @prefix p: . @prefix yago: . @prefix units: . @prefix geonames: . @prefix prv: . @prefix prvTypes: . @prefix doap: . @prefix void: . @prefix ir: . @prefix ou: . @prefix teach: . @prefix time: . @prefix datex: . @prefix aiiso: . @prefix vivo: . @prefix bibo: . @prefix fabio: . @prefix vcard: . @prefix swrcfe: . @prefix frapo: . @prefix org: . @prefix ei2a: . @prefix pto: . vivo:identifier "2001-103"; bibo:page_range "616-620"; ou:vecesCitado "49"; dcterms:creator "Llerena A."; ou:bibtex "@article{RID:0916141122196-39, title = {Effect of thioridazine dosage on the debrisoquine hydroxylation phenotype in psychiatric patients with different CYP2D6 genotypes}, journal = {Therapeutic Drug Monitoring}, year = {2001}, author = {Llerena, A and Berecz, R and de la Rubia, A and Fernandez-Salguero, P and Dorado, P}, volume = {23}, number = {6}, pages = {616-620} }"; dcterms:title "Effect of thioridazine dosage on the debrisoquine hydroxylation phenotype in psychiatric patients with different CYP2D6 genotypes"; ou:eid "2-s2.0-0035187486"; ou:tipoPublicacion "Article"; a ou:Publicacion; vcard:url ; bibo:issn "0163-4356"; dcterms:publisher "Therapeutic Drug Monitoring"; dcterms:contributor "Llerena, A, Berecz, R, de la Rubia, A, Fernandez-Salguero, P, Dorado, P"; fabio:hasPublicationYear "2001"; bibo:doi "10.1097/00007691-200112000-00004"; ou:urlScopus ; ou:urlOrcid ; bibo:volume "23". ou:tienePublicacion . ou:tienePublicacion . ou:tienePublicacion .